Home  /  Resource Library  /  Cardiovascular complications associated with novel agents in the chronic lymphocytic leukemia armamentarium: A pharmacovigilance analysis

Cardiovascular complications associated with novel agents in the chronic lymphocytic leukemia armamentarium: A pharmacovigilance analysis

Study investigated cardiovascular adverse events following treatment with novel agents in people with CLL.